Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rate Tango plans to move the combo approach to a Phase 3 trial

https://www.statnews.com/2026/06/08/pancreatic-cancer-combination-tango-therapeutics-revolution-medicines-vopimetostat-daraxonrasib/ By Andrew JosephJune 8, 2026 Europe Correspondent